A panel of miRNAs in serum extracellular vesicles serves as novel diagnostic biomarkers for MASLD
Biomedical Journal · 2025-12 · 48 (6) · 100838
DOI: 10.1016/j.bj.2025.100838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Journal, 2025-12. Verfasst von Moran Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, MicroRNAs, Fatty Liver. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The rising global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) poses a growing challenge to healthcare systems, stimulating substantial research efforts to develop reliable diagnostic methodologies. Emerging evidence highlights extracellular vesicles (EVs) as promising non-invasive biomarkers due to their roles in metabolic regulation and disease progression. This study investigated the diagnostic potential of serum EV-derived microRNAs (miRNAs) for MASLD detection and staging. We developed a novel diagnostic approach combining wheat germ agglutinin (WGA)-coupled magnetic beads for EV capture with RT-qPCR analysis, creating a streamlined two-step protocol that eliminates conventional purification requirements. MiR-574-3p, miR-542-3p, and miR-200a-3p in serum EVs were significantly elevated in patients with MASLD, indicating their potential as non-invasive biomarkers. Here, our established platform offers a clinically feasible solution for EVs isolation and quantitative miRNA analysis, presenting significant advantages in diagnostic efficiency and practical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China.
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China…
- State Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing Medical University, Nanjing University, Jiangsu, China.
- Institute of Geriatric Medicine, Jiangsu Province Geriatric Hospital, Nanjing, Jiangsu, China.
- The First Clinical College of Nanjing Medical University, Jiangsu, China.
- Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Jiangsu, China.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Hu, M., Huang, H., Jia, M., Xu, M., Chen, M., Wu, J., Gu, S., Liang, H., Zhou, H., & Gong, Y. (2025). A panel of miRNAs in serum extracellular vesicles serves as novel diagnostic biomarkers for MASLD. Biomedical Journal, 48(6), 100838. https://doi.org/10.1016/j.bj.2025.100838
Vancouver
Hu M, Huang H, Jia M, Xu M, Chen M, Wu J, et al. A panel of miRNAs in serum extracellular vesicles serves as novel diagnostic biomarkers for MASLD. Biomedical Journal. 2025;48(6):100838. doi:10.1016/j.bj.2025.100838
BibTeX
@article{Hu2025,
author = {Hu, Moran and Huang, Hai and Jia, Meng and Xu, Min and Chen, Malin and Wu, Junxiang and Gu, Shouyong and Liang, Hongwei and Zhou, Hongwen and Gong, Yingyun},
title = {A panel of miRNAs in serum extracellular vesicles serves as novel diagnostic biomarkers for MASLD},
journal = {Biomedical Journal},
year = {2025},
volume = {48},
number = {6},
pages = {100838},
doi = {10.1016/j.bj.2025.100838}
}
EUVIMED